• Supports adaptation to stress

      • Supports mood

      • Supports brain health and cognitive performance


In Russia, Scandinavia, the Baltic countries, and Asia, Rhodiola Rosea has a long history of folk use as an adaptogenic herb.


Tonic-like properties have been associated with it, such as being used to counter fatigue and enhance the ability to work mentally and physically.


In cold climates, R.Rosea grows in mountainous regions, through Central Asia, in Europe. Researchers in Russia studied (and eventually classified R.rosea as an adaptogen) R.rosea's ability to adapt to extreme temperatures and environments.


This adaptogenic classification of R. Rosea is based on decades of research, with R. Rosea showing resistance to multiple types of stress factors.


A variety of biologically active compounds exist in R.rosea. The main bioactive compounds of rosavins (rosavin, rosin, and rosarian) are salidroside and rosavins.


Rhodiola Rosea is an adaptogenic herb that can increase physical and mental endurance as well as boost energy, alertness, concentration, mental stamina, and mood.


Brain and cognitive function


  • Supports attention, capacity for mental work, and resistance to mental fatigue [1–6]
  • Supports mental and physical performance during stress [1–4]
  • Supports a healthy mood [7–9]
  • Supports serotonin levels [10]
  • Supports neuroplasticity and neurogenesis [11,12]
  • Supports neuroprotective functions [13–18]
  • Supports healthy levels of stress hormones and other stress response mediators [2,19–22]
  • Supports β-endorphin signaling [22,23]
  • Influences monoamine oxidase (MAO) A and B [24,25]
  • Influences acetylcholinesterase [13,25]


Physical stamina


  • Supports resistance to physical fatigue [3]
  • Supports endurance performance [26]
  • Supports exercise-induced antioxidant defenses [27]


Healthy aging


  • Supports the composition of the gut microbiota [14,36–41]

  • Supports gut microbial metabolism [37]

  • Supports gut-immune communication [36,38]

  • Supports mitochondrial function [17,28,29]
  • Supports antioxidant enzymes (superoxide dismutase [SOD], catalase [CAT], glutathione peroxidase [GPX], glutathione reductase [GR]) [13,15,27,30]
  • Supports glutathione and thioredoxin levels [15,17]
  • Extends lifespan (Drosophila melanogaster and Caenorhabditis elegans) [31–33]


Complementary ingredients


  • Ginkgo biloba for cognitive function [34]
  • Saffron for mood support [35]


Morning Momentum

Get Instant Access To A Simple, Proven System That Has Helped


IGNITE Their Health and Energy

to Create The Life They Deserve!

Learn More


[1]V.A. Shevtsov, B.I. Zholus, V.I. Shervarly, V.B. Vol’skij, Y.P. Korovin, M.P. Khristich, N.A. Roslyakova, G. Wikman, Phytomedicine 10 (2003) 95–105.
[2]E.M. Olsson, B. von Schéele, A.G. Panossian, Planta Med. 75 (2009) 105–112.
[3]A.A. Spasov, G.K. Wikman, V.B. Mandrikov, I.A. Mironova, V.V. Neumoin, Phytomedicine 7 (2000) 85–89.
[4]V. Darbinyan, A. Kteyan, A. Panossian, E. Gabrielian, G. Wikman, H. Wagner, Phytomedicine 7 (2000) 365–371.
[5]D. Edwards, A. Heufelder, A. Zimmermann, Phytother. Res. 26 (2012) 1220–1225.
[6]T. Koop, A. Dienel, M. Heldmann, T.F. Münte, Phytother. Res. 34 (2020) 3287–3297.
[7]M. Cropley, A.P. Banks, J. Boyle, Phytother. Res. 29 (2015) 1934–1939.
[8]A. Bystritsky, L. Kerwin, J.D. Feusner, J. Altern. Complement. Med. 14 (2008) 175–180.
[9]V. Darbinyan, G. Aslanyan, E. Amroyan, E. Gabrielyan, C. Malmström, A. Panossian, Nord. J. Psychiatry 61 (2007) 343–348.
[10]C. Mannucci, M. Navarra, E. Calzavara, A.P. Caputi, G. Calapai, Phytomedicine 19 (2012) 1117–1124.
[11]Q.G. Chen, Y.S. Zeng, Z.Q. Qu, J.Y. Tang, Y.J. Qin, P. Chung, R. Wong, U. Hägg, Phytomedicine 16 (2009) 830–838.
[12]C. Concerto, C. Infortuna, M.R.A. Muscatello, A. Bruno, R. Zoccali, E. Chusid, E. Aguglia, F. Battaglia, Complement. Ther. Med. 41 (2018) 141–146.
[13]J. Zhang, Y.-F. Zhen, Pu-Bu-Ci-Ren, L.-G. Song, W.-N. Kong, T.-M. Shao, X. Li, X.-Q. Chai, Behav. Brain Res. 244 (2013) 70–81.
[14]Z.-Q. Qu, Y. Zhou, Y.-S. Zeng, Y.-K. Lin, Y. Li, Z.-Q. Zhong, W.Y. Chan, PLoS One 7 (2012) e29641.
[15]Z.-Q. Qu, Y. Zhou, Y.-S. Zeng, Y. Li, P. Chung, Biomed. Environ. Sci. 22 (2009) 318–326.
[16]S.I. Jang, H.O. Pae, B.M. Choi, G.S. Oh, S. Jeong, H.J. Lee, H.Y. Kim, K.J. Kang, Y.G. Yun, Y.C. Kim, H.T. Chung, Immunopharmacol. Immunotoxicol. 25 (2003) 295–304.
[17]L. Zhang, H. Yu, X. Zhao, X. Lin, C. Tan, G. Cao, Z. Wang, Neurochem. Int. 57 (2010) 547–555.
[18]D.R. Palumbo, F. Occhiuto, F. Spadaro, C. Circosta, Phytother. Res. 26 (2012) 878–883.
[19]A. Panossian, M. Hambardzumyan, A. Hovhanissyan, G. Wikman, Drug Target Insights 2 (2007) 39–54.
[20]A. Panossian, G. Wikman, P. Kaur, A. Asea, Front. Neurosci. 6 (2012) 6.
[21]A. Panossian, G. Wikman, Pharmaceuticals 3 (2010) 188–224.
[22]I.B. Lishmanov, Z.V. Trifonova, A.N. Tsibin, L.V. Maslova, L.A. Dement’eva, Biull. Eksp. Biol. Med. 103 (1987) 422–424.
[23]G.S. Kelly, Altern. Med. Rev. 6 (2001) 293–302.
[24]D. van Diermen, A. Marston, J. Bravo, M. Reist, P.-A. Carrupt, K. Hostettmann, J. Ethnopharmacol. 122 (2009) 397–401.
[25]D. van Diermen, A. Marston, J. Bravo, M. Reist, P.A. Carrupt, K. Hostettmann, Planta Med. 74 (2008) PA202.
[26]K. De Bock, B.O. Eijnde, M. Ramaekers, P. Hespel, Int. J. Sport Nutr. Exerc. Metab. 14 (2004) 298–307.
[27]J. Xu, Y. Li, Mol. Med. Rep. 6 (2012) 1195–1198.
[28]S. Yu, M. Liu, X. Gu, F. Ding, Cell. Mol. Neurobiol. 28 (2008) 1067–1078.
[29]H. Zhong, H. Xin, L.-X. Wu, Y.-Z. Zhu, J. Pharmacol. Sci. 114 (2010) 399–408.
[30]Y. Zhu, Y.-P. Shi, D. Wu, Y.-J. Ji, X. Wang, H.-L. Chen, S.-S. Wu, D.-J. Huang, W. Jiang, DNA Cell Biol. 30 (2011) 809–819.
[31]S.E. Schriner, A. Abrahamyan, A. Avanessian, I. Bussel, S. Maler, M. Gazarian, M.A. Holmbeck, M. Jafari, Free Radic. Res. 43 (2009) 836–843.
[32]M. Jafari, J.S. Felgner, I.I. Bussel, T. Hutchili, B. Khodayari, M.R. Rose, C. Vince-Cruz, L.D. Mueller, Rejuvenation Res. 10 (2007) 587–602.
[33]F.A.C. Wiegant, S. Surinova, E. Ytsma, M. Langelaar-Makkinje, G. Wikman, J.A. Post, Biogerontology 10 (2009) 27–42.
[34]H.M. Al-Kuraishy, J Intercult Ethnopharmacol 5 (2016) 7–13.
[35]M. Bangratz, S.A. Abdellah, A. Berlin, C. Blondeau, A. Guilbot, M. Dubourdeaux, P. Lemoine, Neuropsychiatr. Dis. Treat. 14 (2018) 1821.